pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis

Genes and Development

Volumn 10, Issue 23, 1996, Pages 3051-3064

  Zacksenhaus, Eldad ^a,b   Jiang, Zhe ^a   Chung, Daniel ^c   Marth, Jamey D ^c   Phillips, Robert A ^a   Gallic, Brenda L ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

apoptosis; cell cycle control; differentiation; myogenesis; Retinoblastoma gene

Indexed keywords

RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FETUS; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOPATHY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0029819994     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.23.3051     Document Type: Article

References (84)

1. Andres, V. and K. Walsh. 1996. Myogenin expression, cell cycle withdrawal and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132: 657-666.
2. Bernards, R., G.M. Schackleford, M.R. Gerber, J.M. Horowitz, S.H. Friend, M. Schartl, E. Bogenmann, J.M. Rapaport, T. McGee, T.P. Dryja, and R.A. Weinberg. 1989. Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc. Natl. Acad. Sci. 86: 6474-6478.
3. Bignon, Y.J., Y. Chen, C.Y. Chang, D.J. Riley, J.J. Windle, P.L. Mellon, and W.H. Lee. 1993. Expression of a retinoblastoma transgene results in dwarf mice. Genes & Dev. 7: 1654-1662.
4. Blau, H.M. 1993. Differentiation requires continuous active control. Annu. Rev. Biochem. 61: 1213-1230.
5. Bober, E., G.E. Lyons, T. Braun, G. Cossu, M. Buckingham, and H.H. Arnold. 1991. The muscle regulatory gene, Myf-6, has a biphasic pattern of expression during early mouse development. J. Cell. Biol. 113: 1255-1265.
6. Braun, T. and H.H. Arnold. 1996. myf-5 and myoD genes are activated in distinct mesenchymal stem cells and determine different skeletal muscle cell lineages. EMBO J. 15: 310-318.
7. Braun, T., G. Buschhausen-Denker, E. Bober, E. Tannich, and H.H. Arnold. 1989. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J. 8: 701-709.
8. Braun, T., E. Bober, B. Winter, N. Rosenthal, and H.H. Arnold. 1990. Myf-6, a new member of the human gene family of myogenic determination factors: Evidence for a gene cluster on chromosome 12. EMBO J. 9: 821-831.
9. Buckingham, M. 1992. Making muscle in mammals. Trends Genet. 8: 144-148.
10. Clarke, A.R., E.R. Maandag, M. Van Roon, N.M.T. Van der Lugt, M. Van der Valk, M.L. Hooper, A. Berns, and H. Te Riele. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359: 328-330.
11. Davis, R.L., H. Weintraub, and A.B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51: 987-1000.
12. Defeo-Jones, D., P.S. Huang, R.E. Jones, K.M. Haskell, G.A. Vuocolo, M.G. Hanobik, H.E. Huber, and A. Oliff. 1991. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 352: 251-254.
13. Deng, C., P. Zhang, J.W. Harper, S.J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
14. Dunaief, J.L., B.E. Strober, S. Guha, P.A. Khavari, K. Ålin, J. Luban, M. Begemann, G.R. Crabtree, and S.P. Goff. 1994. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79: 119-130.
15. Edmondson, D.G. and E.N. Olson. 1989. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes & Dev. 3: 628-640.
16. Ewen, M., Y. Xing, J.B. Lawrence, and D. Livingston. 1991. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66: 1155-1164.
17. Fiddler, T.A., L. Smith, S.J. Tapscott, and M.J. Thayer. 1966. Amplification of MDM2 inhibits MyoD-mediated myogenesis. Mol. Cell. Biol. 16: 5048-5057.
18. Field, S.J., F.Y. Tsai, F. Kuo, A.M. Zubiage, W.G. Kaelin, D.M. Livingston, S.H. Orkin, and M.E. Greenberg. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561.
19. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119: 493-501.
20. Gu, W., J.W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72: 309-324.
21. Hagemeier, C., A.J. Bannister, A. Cook, and T. Kouzarides. 1993. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Pioc. Natl. Acad. Sci. 90: 1580-1584.
22. Halevy, O., B.C. Novitch, D.B. Spicer, S.X. Skapek, I. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
23. Hannon, G.J., D. Demetrick, and D. Beach. 1993. Isolation of the Rb-related p 130 through its interaction with CDK2 and cyclins. Genes & Dev. 7: 2378-2391.
24. Hasty, P., A. Bradley, J.H. Morris, D.G. Edmondson, J.M. Venuti, E.N. Olson, and W.H. Klein. 1993. Muscle defi- ciency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364: 501-506.
25. Hijmans, E.M., P.M. Voorhoeve, R.L. Beijersbergen, L.J. van't Veer, and R. Bernards. 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15: 3082-3089.
26. Hinterberger, T.J., D.A. Sassoon, S.J. Rhodes, and S.F. Konieczny. 1991. Expression of the muscle regulatory factor MRF4 during somite and skeletal myofiber development. Dev. Biol. 147: 144-156.
27. Hong, F.D., H.-J.S. Huang, H. To, L.J. Young, A. Oro, R. Bookstein, E.Y. Lee, and W.H. Lee. 1989. Structure of the human retinoblastoma gene. Proc. Natl. Acad. Sci. 86: 5502-5506.
28. Huang, S., W.-H. Lee, and E.Y.-H.P. Lee. 1991. A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product. Nature 350: 160-162.
29. Hui, C.C., D. Slusarski, K.A. Platt, R. Holmgren, and A.L. Joynet. 1994. Expression of three mouse homologs of the Drosophila segment polarity gene cubitus interruptus, Gli, Gli-2, and Gli-3, in ectoderm- and mesoderm-derived tissues suggests multiple roles during postimplantation development. Dev. Biol. 162: 402-413.
30. Jacks, T., A. Fazeli, E.M. Schmitt, R.T. Bronson, M.A. Goodell, and R.A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295-300.
31. Jegalian, B.C. and E.M. De Robertis. 1992. Homeotic transformations in the mouse induced by overexpression of a human Hox3.3 transgene. Cell 71: 901-910.
32. Kim, S.J., S. Wagner, F. Liu, M.A. O'Reilly, P.D. Robbins, and M.R. Green. 1992. Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature 358: 331-334.
33. Kuhar, S.G. and J.M. Lehman. 1991. T antigen and p53 in pre- and post-crisis simian virus 40-transformed human cell lines. Oncogene 6: 1499-1506.
34. Lakso, M., B. Sauer, B. Mosinger, E.J. Lee, R.W. Manning, S.-H. Yu, K.L. Mulder, and H. Westphal. 1992. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl. Acad. Sci. 89: 6232-5236.
35. Lee, E.Y.-H.P., C.Y. Chang, N. Hu, Y.C.J. Wang, C.C. Lai, K. Herrup, W.H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294.
36. Lee, E.Y.-H.P., N. Hu, S.-S.F. Yuan, L.A. Cox, A. Bradley, W.-H. Lee, and K. Herrup. 1994. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes & Dev. 8: 2008-2021.
37. Lee, M.H., B.O. Williams, G. Mulligan, S. Mukai, R.T. Bronson, N. Dyson, E. Harlow, and T. Jacks. 1996. Targeted disruption of p107: Functional overlap between p107 and Rb. Genes & Dev. 10: 1621-1632.
38. Li, Y., C. Graham, S. Lacy, A.M. Duncan, and P. Whyte. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes & Dev. 7: 2366-2377.
39. Lufkin, T., M. Mark, C.P. Hart, P. Dolle, M. LeMeur, and P. Chambon. 1992. Homeotic transformation of the occipital bones of the skull by ectopic expression of a homeobox gene. Nature 359: 835-841.
40. Lyons, G.E., S. Muhlebach, A. Moser, R. Masood, B.M. Paterson, M.E. Buckingham, and J.C. Perriard. 1991. Developmental regulation of creatine kinase gene expression by myogeninenic factors in embryonic mouse and chick skeletal muscle. Development 113: 1017-1029.
41. Maandag, E.C.R., M. Van der Valk, M. Vlaar, C. Feltkamp, J. O'Brien, M. Van Roon, N. Van der Lugt, A. Berns, and H. Te Riele. 1994. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13: 4260-4268.
42. Miner, J.H. and B.J. Wold. 1990. Herculin, a fourth member of MyoD family of myogenic regulatory genes. Proc. Natl. Acad. Sci. 87: 1089-1093.
43. Molkentin, F.D., B.L. Black, J.F. Martin, and E.N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogeninenic bHLH proteins. Cell 83: 1125-1136.
44. Morgenbesser, S.D., B.O. Williams, T. Jacks, and R.A. DePinho. 1994. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371: 72-74.
45. Morshead, C.M., B.A. Reynolds, G.G. Craig, M.W. McBurney, W.A. Staines, D. Morassutti, S. Weiss, and D. van der Kooy. 1994. Neural stem cells in the adult mammalian forebrain: A relatively quiescent subpopulation of subependymal cells. Neuron 13: 1071-1082.
46. Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, and I. Nonaka. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364: 532-535.
47. Nowakowski, R.S., S.B. Lewin, and M.W. Miller. 1989. Bromodeoxyuridine immunohistochemical determination of the lengths of the cell cycle and the DNA-synthetic phase for an anatomically defined population. J. Neurocytol. 18: 311-318.
48. Olson, E.N. and W.H. Klein. 1994. bHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out. Genes & Dev. 8: 1-8.
49. Olson, E.N., H.H. Arnold, P.W.J. Rigby, and B.J. Wold. 1996. Know your neighbors: Three phenotypes in null mutants of the myogeninenic bHLH gene MRF4. Cell 85: 1-4.
50. Orban, P.C., D. Chui, and J.D. Marth. 1992. Tissue- and sitespecific DNA recombination in transgenic mice. Proc. Natl. Acad. Sci. 89: 6861-6865.
51. Omitz, D.M., R.E. Hammer, A. Messing, R.D. Palmiter, and R.L. Brinster. 1987. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science 238: 188-193.
52. Palmiter, R.D., E.P. Sandgren, M.R. Avarbock, D.D. Allen, and R.L. Brinster. 1991. Heterologous introns can enhance expression of transgenes in mice. Proc. Natl. Acad. Sci. 88: 478-482.
53. Parker, S.B., G. Eichele, P. Zhang, A. Rawls, A.T. Sands, A. Bradley, E.N. Olson, J.W. Harper, and S.J. Elledge. 1995. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
54. Pin, C.L. and P.A. Merrifield. 1993. Embryonic and fetal rat myoblasts express different phenotypes following differentiation in vitro. Dev. Genet. 14: 356-368.
55. Rhodes, S.J. and S.F. Konieczny. 1989. Identification of MRF4: A new member of the muscle regulatory factor gene family. Genes & Dev. 3: 2050-2061.
56. Rinehart, C.A., J.P. Mayben, T.D. Butler, J.S. Haskill, and D.G. Kaufman. 1992. Alterations of DNA content in human endometrial stromal cells transfected with a temperature-sensitive SV40: Tetraploidization and physiological consequences. Carcinogen 13: 63-68.
57. Rinehart, C.A., C.H. Laundon, J.P. Mayben, B.D. Lyn-Cook, and D.G. Kaufman. 1993. Conditional immortalization of human endometrial stromal cells with a temperature-sensitive simian virus 40. Carcinogen 14: 993-999.
58. Rudnicki, M.A., P.N. Schnegelsberg, R.H. Stead, T. Braun, H.H. Arnold, and R. Jaenisch. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75: 1351-1359.
59. Sardet, C., M. Vidal, D. Cobrinik, Y. Geng, C. Onufryk, A. Chen, and R.A. Weinberg. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. 92: 2403-2407.
60. Sassoon, D.A., I. Gamer, and M. Buckingham. 1988. Transcripts of alpha-cardiac and alpha-skeletal actins are early markers for myogenesis in the mouse embryo. Development 104: 155-164.
61. Sassoon, D.A., G. Lyons, W.E. Wright, V. Lin, A. Lassar, H. Weintraub, and M. Buckingham. 1989. Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. Nature 341: 303-307
62. -/- muscle cells. Science 264: 1467-1471.
63. Seigel, G.M. and M.F. Notter. 1993. Differentiation of Y79 retinoblastoma cells induced by succinylated concanavalin A. Cell Growth Diff. 4: 1-7.
64. Seigel, G.M., J. Tombran-Tink, S.P. Becerra, G.J. Chader, D.A. Diloreto, Jr., C. Del Cerro, E.S. Lazar, and M. Del Cerro. 1994. Differentiation of Y79 retinoblastoma cells with pigment epithelial-derived factor and interphotoreceptor matrix wash: Effects on tumorigenicity. Growth Factors 10: 289-297.
65. 1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
66. Singh, P., J. Coe, and W. Hong. 1995. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 374: 562-565.
67. Skapek, S.X., J. Rhee, D.B. Spicer, and A.B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267: 1022-1024.
68. Vairo, G., D.M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes & Dev. 9: 869-881.
69. Wang, C.Y., B. Petryniak, C.B. Thompson, W.G. Kaelin, and J.M. Leiden. 1993. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science 260: 1330-1335.
70. Wang, J. and K. Walsh. 1996. Resistance to apoptosis conferred by cdk inhibitors during myocyte differentiation. Science 273: 359-361.
71. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
72. Weintraub, H. 1993. The MyoD family and myogenesis: Redundancy, networks, and thresholds. Cell 75: 1241-1244.
73. Weintraub, S.J., C.A. Prater, and D.C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358: 259-261.
74. Weintraub, S.J., K.N.B. Chow, R.X. Luo, S.H. Zhang, S. He, and D.C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375: 812-815.
75. Welch, P.J. and J.Y. Wang. 1993. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75: 779-790.
76. Williams, B.O., E.M. Schmitt, L. Remington, R.T. Bronson, D.M. Albert, R.A. Weinberg, and T. Jacks. 1994. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13: 4251-4259.
77. Wright, W.E., D.A. Sassoon, and V.K. Lin. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56: 607-617.
78. Xiao, Z.-X., J. Chen, A.J. Levine, N. Modjtahedi, J. Xing, W.R. Sellers, and D.M. Livingston. 1995. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375: 694-698.
79. Yamasaki, L., T. Jacks, R. Bronson, E. Goulot, E. Harlow, and N.J. Dyson. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548.
80. Zacksenhaus, E., R. Bremner, Z. Jiang, R.M. Gill, M. Muncaster, M. Sopta, R.A. Phillips, and B.L. Gallic. 1993a. Unraveling the function of the retinoblastoma gene. Adv. Cancer Res. 61: 115-141.
81. Zacksenhaus, E., R. Bremner, R.A. Phillips, and B.L. Gallic. 1993b. A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. Mol. Cell. Biol. 13: 4588-4599.
82. Zacksenhaus, E., R.M. Gill, R.A. Phillips, and B.L. Gallic. 1993c. Molecular cloning and characterization of the mouse RB1 promoter. Oncogene 8: 2343-2351.
83. Zacksenhaus, E., Z. Jiang, R.A. Phillips, and B.L. Gallic. 1996. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product. EMBO J. (in press).
84. Zhang, W., R.R. Behringer, and E.N. Olson. 1995. Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. Genes &. Dev. 9: 1388-1399.